HIGHLIGHTS
- who: . and colleagues from the University of Wolverhampton, United Kingdom have published the research work: Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas, in the Journal: (JOURNAL)
- what: The authors explored the role of FDX1 in human pancancer by transcritomic analysis.
- how: The cox regression results were shown by the forest plot. OS results showed that expression of FDX1 was risk factor in glioma (GBMLGG) (HR=4.17 p=1.7e-19) LGG (HR=2.92 p=9.5e-6 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.